LAVA Therapeutics
Entry
2020
Hold
1yr
Exit
2021
Who owns LAVA Therapeutics?
LAVA Therapeutics was owned by Ysios Capital Partners through Ysios BioFund III (2020 vintage) from 2020 to 2021, exited via IPO.
Hand-verified · updated 2026-08-03
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2021
More from Ysios BioFund III
Other portfolio companies in the same fund.
CH
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track LAVA Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy LAVA Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on LAVA Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue